Algoritm vedeniya patsientov s vnebol'nichnoy pnevmoniey v ambulatornoy praktike
- Authors: Zaytsev A.A1, Sinopal'nikov A.I1
-
Affiliations:
- Государственный институт усовершенствования врачей МО РФ, Москва
- Issue: Vol 11, No 11 (2009)
- Pages: 87-92
- Section: Articles
- URL: https://bakhtiniada.ru/2075-1753/article/view/93090
- ID: 93090
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. A Zaytsev
Государственный институт усовершенствования врачей МО РФ, Москва
A. I Sinopal'nikov
Государственный институт усовершенствования врачей МО РФ, Москва
References
- Чучалин А.Г., Синопальников А.И., Страчунский Л.С. и др. Внебольничная пневмония у взрослых. Практические рекомендации по диагностике, лечению и профилактике. М.: OOO «Изд - кий дом «М - Вести», 2006.
- Woodhed M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138–80.
- Mandell L, Richard G et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community - Acquired Pneumonia in Adults. Доступно на: http://www.thoracic.org/sections/publications/statements/pages/mtpi/idsaats-cap.html.
- Jokinen C, Heiskanen L, Juvonen H et al. Microbial etiology of community - acquired pneumonia in the adult population of 4 municipalities in Eastern Europe. Clin Infect Dis 2001; 32: 1141–54.
- Marrie T.J., Peeling R.W., Fine M.J. et al. Ambulatory patients with community - acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996; 101: 508–15.
- Niederman M. Cost - effective antibiotic management of community - acquired pneumonia. Eur Respir Mon 2004; 28: 198–210.
- Fine M.J., Auble T.E., Yealy D.M. et al. A prediction rule to identify low - risk patients with community - acquired pneumonia.N Engl J Med 1997; 336: 243–50.
- Lim W.S., van der Eerden M.M., Laing R et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377–82.
- Amsden G.W., Amankwa K. Pneumococcal resistance: The treatment challenge. Ann Pharmacother 2001; 35 (4): 480–8.
- Козлов Р.С., Сивая О.В., Шпынев К.В. и др. Антибиотикорезистентность Streptococcus pneumoniae в России в 1999–2005 гг.: результаты многоцентровых проспективных исследований Пегас I и Пегас II. Клин. микробиол. и антимикроб. химиотер. 2006; 8 (1): 33–47.
- Feikin D.R., Schuchat A, Kolczak M et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Public Health 2000; 90: 223–9.
- Hyde T.B., Gay K, Stephens D.S. et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 2001; 286: 1857–62.
- Clavo-Sanchez A.J., Giron-Gonzalez J.A., Lopez-Prieto D et al. Multivariate analysis of risk factors for infection due to penicillin - resistant and multidrug - resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 1997; 24: 1052–9.
- Ho P.L., Tse W.S., Tsang K.W. et al. Risk factors for acquisition of levofloxacin - resistant Streptococcus pneumoniae: a case - control study. Clin Infect Dis 2001; 32: 701–7.
- Ruhe J.J., Hasbun R. Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance. Clin Infect Dis 2003; 36: 1132–8.
- Guay D. Short - course antimicrobial therapy of respiratory tract infections. Drugs 2003; 63: 2169–84.
- Barron et al. 2004. Personal communication.
- Roson B, Carratala J, Fernandez-Sabe N et al. Causes and factors associated with early failure in hospitalized patients with community - acquired pneumonia. Arch Intern Med 2004; 164: 502–8.
- Kothe H, Bauer T, Marre R. Outcome of community - acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 2008; 32: 139–46.
- Рачина С.А., Зайцев А.А. Фармакоэпидемиологические исследования антибактериальных препаратов при внебольничных инфекциях дыхательных путей. В кн.: Внебольничные инфекции дыхательных путей: диагностика и лечение. Руководство для врачей. М.: ООО «М - Вести», 2008; 254–71.
- Drehobl M.A., De Salvo M.C., Lewis D.E., Breen J.D. Single - dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild - to - moderate community - acquired pneumonia in adults. Chest 2005; 128 (4): 2230–7.
- Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double - blind trial. Lancet 2002; 360 (9336): 835–41.
- РОМИР Мониторинг 2007, http://ru-romir.com.
- Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortal. Morbid. Wkly Rep 1997; 46 (R-8).
Supplementary files
